Processa Pharmaceuticals, Inc. (PCSA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.77M |
| Enterprise Value | -1.77M |
| P/E Ratio | -0.24 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | -11.7 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | -0.26 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
AD
Management Effectiveness
| Return On Assets | -6.49 |
| Return On Equity | -3.94 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -13.56M |
| Net Income | -13.56M |
| Diluted EPS | -10.36 |
Balance Sheet
| Total Cash | 196,325 |
| Total Cash/Share | 0.07 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 0.87 |
| Book Value Per Share | -0.12 |
Price History
| 52-Week Change | -88.72 |
| 52-Week High | 11.08 |
| 52-Week Low | 1.35 |
| Moving Average 50 Days | 2.03 |
| Moving Average 200 Days | 2.5 |
Statistics
| Average Volume | 224,790 |
| Shares Outstanding | 2.77M |
| % Held by Institutions | 4.31 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | December 17, 2025 |
AD
